Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis

Transplant International

Volumn 21, Issue 11, 2008, Pages 1102-

  Meyer, Tobias N ^a   Thaiss, Friedrich ^a   Stahl, Rolf A K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

DRUG EFFECT; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY TRANSPLANTATION; LETTER; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; TREATMENT FAILURE;

ANTIBODIES, MONOCLONAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; PROTEINURIA; RECURRENCE; TIME FACTORS;

EID: 53749089397     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00718.x     Document Type: Letter

References (5)

1. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2007 20 : 1066.
2. Deegens KJ, Wetzels JFM. Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation. NDT Plus 2008 1 : 85.
3. Hristea D, Hadaya K, Marangon N, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007 20 : 102.
4. Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007 20 : 558.
5. Yabu JM, Ho B, Scandling JD, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008 8 : 222.